Press Releases

 
Press Releases
  Date Title View
Jan 25, 2016
LYON, France, Jan. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Sylvester Comprehensive Cancer Center, Miami, using FDA approved Ablatherm Robotic HIFU. Sylvester Center will serve as the Ablatherm HIFU training and proctori...
Jan 19, 2016
LYON, France, Jan. 19, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the publication of long term results of Ablatherm Focal HIFU in the peer reviewed journal "Prostate Cancer and Prostatic Diseases," part of the Nature Publishing Group. This pioneering prospective study of H...
Jan 6, 2016
LYON, France, Jan. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Japanese subsidiary, Edap Technomed Japan, has secured Japanese PMDA approval for the Quanta Litho Laser. By gaining this approval, Edap Technomed Japan has been granted exclusive marketing and distribut...
Dec 21, 2015
LYON, France, Dec. 21, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale of an Ablatherm Robotic HIFU device to Sylvester Comprehensive Cancer Center, part of UHealth - the University of Miami Health System. Dipen J. Parekh, M.D., a robotic surgeon and urologic oncolog...
Dec 11, 2015
LYON, France, Dec. 11, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Russia's Federal Service for Surveillance in Healthcare (Roszdravnadzor) has approved Focal One for sale in Russia. Russia is currently the largest market for EDAP's Ablatherm® robotic HIFU technology. ...
Dec 9, 2015
LYON, France, Dec. 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first installation of Ablatherm Robotic HIFU at University of Southern California, Keck Medicine of USC, which will become the first reference and training center for Ablatherm Robotic HIFU in the U.S. D...
Nov 24, 2015
LYON, France, Nov. 24, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced data from a multicenter trial demonstrating encouraging outcomes of focal HIFU as a new treatment strategy for patients with unilateral localized prostate cancer. The dataset was presented in a poster sessi...
Nov 18, 2015
Obtained FDA clearance for Ablatherm® HIFU in November Received first four U.S. orders for Ablatherm Record nine-month net sales of €20.5 million HIFU treatment-driven revenue increased 41% year-over-year Strong backlog for both lithotripsy and HIFU divisions entering Q4 First Focal One&#...
Nov 12, 2015
LYON, France, Nov. 12, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the third quarter ended September 30, 2015 on Wednesday, November 18, 2015, after the close of trading. Company management will host a conference call on Thurs...
Nov 12, 2015
LYON, France, Nov. 12, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it signed contracts for the sale of three Ablatherm® HIFU devices to prominent U.S. urology groups. The Company expects to start shipping systems from its manufacturing facility in France to U.S. ...
1
... NextLast
= add release to Briefcase